CN113136394A - Expression vector of membrane protein CcmB and expression purification method thereof - Google Patents
Expression vector of membrane protein CcmB and expression purification method thereof Download PDFInfo
- Publication number
- CN113136394A CN113136394A CN202010048422.1A CN202010048422A CN113136394A CN 113136394 A CN113136394 A CN 113136394A CN 202010048422 A CN202010048422 A CN 202010048422A CN 113136394 A CN113136394 A CN 113136394A
- Authority
- CN
- China
- Prior art keywords
- expression
- ccmb
- membrane protein
- escherichia coli
- expression vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010052285 Membrane Proteins Proteins 0.000 title claims abstract description 34
- 102000018697 Membrane Proteins Human genes 0.000 title claims abstract description 33
- 239000013604 expression vector Substances 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 16
- 238000000746 purification Methods 0.000 title claims abstract description 10
- 241000588724 Escherichia coli Species 0.000 claims abstract description 28
- 102000034287 fluorescent proteins Human genes 0.000 claims abstract description 14
- 108091006047 fluorescent proteins Proteins 0.000 claims abstract description 14
- 108091026890 Coding region Proteins 0.000 claims abstract description 8
- 108020004705 Codon Proteins 0.000 claims abstract description 8
- 238000003776 cleavage reaction Methods 0.000 claims abstract description 8
- 230000007017 scission Effects 0.000 claims abstract description 8
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000545067 Venus Species 0.000 claims abstract description 6
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 6
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 6
- 102000005927 Cysteine Proteases Human genes 0.000 claims abstract description 4
- 108010005843 Cysteine Proteases Proteins 0.000 claims abstract description 4
- 241000701832 Enterobacteria phage T3 Species 0.000 claims abstract description 4
- 241000723792 Tobacco etch virus Species 0.000 claims abstract description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000002773 nucleotide Substances 0.000 claims abstract 2
- 125000003729 nucleotide group Chemical group 0.000 claims abstract 2
- 239000002609 medium Substances 0.000 claims description 14
- 230000006698 induction Effects 0.000 claims description 12
- 239000001963 growth medium Substances 0.000 claims description 7
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 239000013613 expression plasmid Substances 0.000 claims description 4
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 238000012216 screening Methods 0.000 abstract description 3
- 238000013537 high throughput screening Methods 0.000 abstract description 2
- 239000003550 marker Substances 0.000 abstract description 2
- 239000013612 plasmid Substances 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 9
- 238000010586 diagram Methods 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 238000000799 fluorescence microscopy Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 108010077805 Bacterial Proteins Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 102000035160 transmembrane proteins Human genes 0.000 description 2
- 108091005703 transmembrane proteins Proteins 0.000 description 2
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 108010042653 IgA receptor Proteins 0.000 description 1
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Abstract
The invention discloses an expression vector of a membrane protein CcmB and an expression and purification method thereof. The nucleotide sequence of the expression vector is shown as SEQ ID NO.2, and the expression vector comprises: the bacteriophage T7 promoter; an escherichia coli ribosome binding site which comprises an NcoI sequence CCATGG, an escherichia coli membrane protein CcmB sequence shown in SEQ ID NO.1 and a BamHI site GGATCC; a tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; NdeI restriction site CATATG; a hyper-folding Venus fluorescent protein coding sequence; XhoI cleavage site CTCGAG; 6 histidine sites and the stop codon TAG. The invention uses the fluorescent protein with rigid molecules as a screening marker and an expression process indicator, and the fluorescent protein can be quickly folded due to the rigid structure with molecular level, and can help the nitrogen-terminal membrane protein Ccmc to stabilize the conformation. The expression vector constructed by the invention can realize the mass expression of the membrane protein Ccmc, and can be used for the high-throughput screening of the subsequent novel antibiotics.
Description
Technical Field
The invention belongs to the technical field of protein production, and relates to an expression vector of a membrane protein heme secretory protein B subunit (Ccmc) and an expression and purification method thereof.
Background
The cell membrane is the boundary between the inside and the outside of the cell, is an important organelle, and plays important roles in information transfer, energy transmission and material exchange. The target of the drug action is often located on the cell membrane. It is currently known that more than 50% of the targets for drug action are membrane proteins. Therefore, the method has very important significance for the research of the membrane protein.
However, since the membrane protein has a few natural states and a multi-transmembrane structure, the membrane protein is easy to be folded mistakenly and has a complex structure, and thus, the large-scale preparation of the membrane protein is always a difficult point and a hot point. In China, no biological company can express transmembrane proteins for more than 12 times, and only one or two companies can express transmembrane proteins for four times.
Coli has been the first choice for protein expression as a commonly used expression host, however, even the proteins of e.coli themselves are difficult to express in large amounts in e.coli. Currently, abuse of antibiotics causes a dilemma that the antibiotics cannot resist drug-resistant bacteria within 50 years. Therefore, a great amount of expression membrane protein is used as an action target of the antibiotic, and a pilot technical support is provided for the high-throughput screening of the subsequent non-denaturing mass spectrum.
Disclosure of Invention
The invention aims to provide an expression vector for expressing a large amount of membrane protein heme secretion protein B subunit (Ccmc) and an expression and purification method thereof. The invention establishes a high-efficiency fusion expression system aiming at the escherichia coli membrane protein CcmB, and can be used for the subsequent further research on the non-denatured real-time monitoring mass spectrum of the protein.
The technical scheme for realizing the purpose of the invention is as follows:
the expression vector of the membrane protein Ccmc takes the hyper-folding Venus fluorescent protein (Chinese patent application 201910347575.3) which is obtained in the laboratory and used for positioning the Chlamydomonas reinhardtii protein as an initial protein skeleton, and obtains a fluorescent protein expression label with rigid molecules by further optimizing the composition of codons used for sequence expression, and is suitable for large-scale expression of the Escherichia coli membrane protein. The invention utilizes the fluorescent protein with rigid molecules as a screening marker and an expression process indicator, and the fluorescent protein can be quickly folded due to the rigid structure with molecular level and helps the nitrogen-terminal membrane protein Ccmc to stabilize the conformation.
The expression vector of the membrane protein CcmB is expression plasmid pLy077-CcmB (SEQ ID NO.2), and comprises: the bacteriophage T7 promoter; an Escherichia coli ribosome binding site comprising an NcoI sequence CCATGG, an Escherichia coli membrane protein CcmB sequence (SEQ ID NO.1) and a BamHI site GGATCC; a tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; NdeI restriction site CATATG; a hyper-folding Venus fluorescent protein coding sequence; XhoI cleavage site CTCGAG; 6 histidine sites and the stop codon TAG.
The invention also provides an expression and purification method of the expression vector of the membrane protein Ccmc, which comprises the following specific steps:
and 2, inoculating the selected mutant strain transformant into a culture medium for amplification culture, and carrying out large-scale induction expression on the membrane protein Ccmc by using 1mM IPTG.
Preferably, in step 1, the Escherichia coli is Escherichia coli BL21(DE3) or Escherichia coli C43(DE 3).
Preferably, in step 2, the culture medium is an LB culture medium or a TB culture medium.
The invention introduces the target gene and the codon optimized hyper-folding Venus fluorescent protein with molecular rigidity into the expression vector by fully synthesizing the expression vector, and greatly improves the transcription and translation efficiency of the target gene by optimizing the primary sequence of the nucleic acid coding. In addition, the folding speed of the carboxyl-terminal rigid fluorescent protein is controlled, so that the target membrane protein is helped to be correctly folded and inserted into the membrane. The rigid fluorescent protein can be used for monitoring the real-time expression process of the protein and protecting the carboxyl terminal of the protein, so that the target protein is enriched. The invention realizes high-flux screening of novel antibiotics through mass expression and later purification of escherichia coli membrane protein, and has important commercial prospect.
Drawings
FIG. 1 is a diagram showing the result of PCR agarose gel electrophoresis of the CcmB protein coding sequence.
FIG. 2 is a schematic structural diagram of the pLy077-CcmB plasmid.
FIG. 3 is a diagram showing the results of PCR verification of pLy077-CcmB colonies.
FIG. 4 shows the results of single-restriction double-restriction agarose gel electrophoresis of plasmid pLy077-CcmB with NcoI and BamHI.
FIG. 5 is a diagram showing the results of sequencing verification of the recombinant plasmid.
FIG. 6 is a graph of the growth of pLy 077-Ccmc in different expression strains and media.
FIG. 7 is a fluorescence image of colonies on transformed agar plates.
FIG. 8 is fluorescence imaging after induction in LB medium and comparison of whole bacterial proteins before and after induction, using Escherichia coli BL21 as expression strain.
FIG. 9 is fluorescence imaging after induction in TB medium and comparison of total mycoprotein before and after induction using Escherichia coli C43 as expression strain.
Detailed Description
The invention will be further described with reference to specific embodiments and figures, but is not limited thereto. The procedures, conditions, reagents, experimental methods and the like for carrying out the present invention are general knowledge and common general knowledge in the art except for the contents specifically mentioned below, and the present invention is not particularly limited.
The materials used in the examples are as follows:
1. cell source
Coli strains DH5 α, BL21(DE3), C41(DE3), C43(DE3) were purchased from Wuhanling vast Bio Inc.
2. Source of plasmids
The pLy077 plasmid and the CcmB coding sequence were synthesized by shanghai bio-inc, the pLy077 plasmid containing: the bacteriophage T7 promoter; coli ribosome binding site comprising the NcoI sequence CCATGG and BamHI site GGATCC; a tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; NdeI restriction site CATATG; a hyper-folding Venus fluorescent protein coding sequence; XhoI cleavage site CTCGAG; 6 histidine sites and the stop codon TAG. pLy077 plasmid and the CcmB coding sequence are shown in the sequence listing.
3. Source of primers
The synthetic primers were all from Biotechnology, Inc. of Ongbenaceae, Beijing.
4. Primary reagent
Tryptone, yeast extract, NaCl, Tris-baes were purchased from Sigma; restriction endonucleases, phusion enzymes, were purchased from Thermo Fisher; rTaq enzyme, T4 ligase, was purchased from Takara. The plasmid miniprep kit and the gel recovery kit were purchased from Axygen corporation. NTP, DEPC water and RNase inhibitor were purchased from Shanghai Biotechnology Ltd.
Example 1 cloning of the Gene of CcmB
Cloning of CcmB
a) A completely new CcmB coding sequence (SEQ ID NO.1) was designed and synthesized based on the comparison of the codon used in the CcmB sequence with the frequency of the Escherichia coli codon usage in the Kazusa online database (http:// www.kazusa.or.jp/codon /). And then amplified by a PCR method. The PCR reaction system configuration is shown in Table 1.
TABLE 1 PCR reaction System preparation Table
Name of reagent | Stock solution concentration | Volume added to PCR reaction System(μL) |
5× |
5× | 10 |
dNTP Mix | 10mmol/ |
2 |
Forward primer | 10μmol/L | 2.5 |
Reverse primer | 10μmol/L | 2.5 |
Phusion enzyme | 5U/μL | 0.5 |
DNA template | 50ng/ |
2 |
MilliQ H2O | Adding MilliQ H2O to a final volume of 50. mu.L |
The PCR results are shown in FIG. 1. The target fragment length is 681bp, and the optimal annealing temperature is 52 ℃.
b) Recovering target DNA, cutting the target fragment and pLy077 plasmid by using Nco I and BamHI enzyme, then carrying out agarose gel electrophoresis, and recovering a cut enzyme product; the recovered target fragment and the pLy077 plasmid fragment were added to a small centrifuge tube at a molar ratio of 5:1, and T4 ligase was added thereto and ligated at 16 ℃ overnight.
c) mu.L of the above ligation product was transformed into 80. mu.L of DH 5. alpha. competent cells by heat shock at 42 ℃ and 700. mu.L of LB medium was added thereto, followed by shaking at 37 ℃ and culturing at 200 rpm for 45 minutes.
d) Centrifuging the bacterial liquid at the rotating speed of 4000 rpm for 1 minute, and sucking 700 mu L of supernatant; after the remaining medium was gently aspirated by a pipette, the medium was spread on an LB solid plate containing ampicillin, and the plate was placed upside down in an incubator at 37 ℃ and cultured for 12 hours.
e) And (3) selecting a single colony in the plate, extracting plasmids after a small amount of amplification, carrying out single enzyme digestion and double enzyme digestion on the extracted plasmids by using Nco I and BamHI, carrying out agarose gel electrophoresis identification, and carrying out sequencing identification to obtain an expression vector pLy077-CcmB of the membrane protein CcmB, wherein the structural schematic diagram of the plasmids is shown in FIG. 2. FIG. 3 is a diagram showing the results of PCR verification of pLy077-CcmB colonies. FIG. 4 shows the results of single-restriction double-restriction agarose gel electrophoresis of plasmid pLy077-CcmB with NcoI and BamHI. FIG. 5 is a diagram showing the results of sequencing verification of the recombinant plasmid.
Example 2 expression of CcmB induced expression of fusion protein CcmB-Superfolder fluorescent protein
The correctly identified pLy 077-CmcmB plasmid was transferred into E.coli expression hosts BL21(DE3) and C43(DE3) and spread on a single colony containing 0.1mM isopropyl thiogalactoside (IPTG) to obtain a stably transformed single colony; by detecting the fluorescence of the colonies, fig. 7 is a fluorescence chart of the colonies on the transformed agar plate, and it can be seen from the presence or absence of fluorescence that whether the colonies contain the recombinant plasmid or not, and the colonies containing the recombinant plasmid show fluorescence, and it can be seen that a mutant strain expressing a large amount of the target protein is obtained.
Each colony was inoculated into LB and TB liquid media containing 100. mu.g/ml ampicillin, and cultured overnight at 37 ℃ at 200 rpm to give overnight-cultured bacteria. The overnight bacteria were inoculated into 750mL LB and TB medium at a ratio of 1:250 and cultured at 30 ℃ to OD at 230 rpm600Reaching 0.8-1.0, adding IPTG with final concentration of 0.5mM, and culturing at 25 deg.C for 2-6 hr. The cells were collected by centrifugation at 4000 rpm for 15 minutes. And (3) suspending the thalli in a PBS buffer solution, and centrifuging for 15 minutes at 4000 rpm to obtain the thalli containing the CcmB fusion expression protein. FIG. 6 is a graph showing the growth of pLy 077-Ccmc in different expression strains and culture media, and from the growth graph, it can be seen that the bacteria can grow to a higher cell concentration in TB medium than in LB medium, i.e., the growth is better. FIG. 8 is a graph showing fluorescence imaging after induction in LB medium and comparison of whole bacterial proteins before and after induction using E.coli BL21 as an expression strain, and it can be seen from FIG. 8 that CcmB protein expression level is the highest after induction for 4 hours in LB medium using E.coli BL21 as an expression strain. FIG. 9 is fluorescence imaging after induction in TB medium and comparison of total mycoprotein before and after induction using Escherichia coli C43 as expression strain. As seen from FIG. 9, the expression level of CcmB protein was the highest after 6 hours of induction in TB medium using E.coli C43 as the expression strain.
Sequence listing
<110> Nanjing university of science and technology
Expression vector of <120> membrane protein CcmB and expression purification method thereof
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 660
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atgatgtttt ggcgcatttt tcgcctggaa ctgcgcgtgg cgtttcgcca tagcgcggaa 60
attgcgaacc cgctgtggtt ttttctgatt gtgattaccc tgtttccgct gagcattggc 120
ccggaaccgc agctgctggc gcgcattgcg ccgggcatta tttgggtggc ggcgctgctg 180
agcagcctgc tggcgctgga acgcctgttt cgcgatgatc tgcaggatgg cagcctggaa 240
cagctgatgc tgctgccgct gccgctgccg gcggtggtgc tggcgaaagt gatggcgcat 300
tggatggtga ccggcctgcc gctgctgatt ctgagcccgc tggtggcgat gctgctgggc 360
atggatgtgt atggctggca ggtgatggcg ctgaccctgc tgctgggcac cccgaccctg 420
ggctttctgg gcgcgccggg cgtggcgctg accgtgggcc tgaaacgcgg cggcgtgctg 480
ctgagcattc tggtgctgcc gctgaccatt ccgctgctga tttttgcgac cgcggcgatg 540
gatgcggcga gcatgcatct gccggtggat ggctatctgg cgattctggg cgcgctgctg 600
gcgggcaccg cgaccctgag cccgtttgcg accgcggcgg cgctgcgcat tagcattcag 660
<210> 2
<211> 6655
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
tggcgaatgg gacgcgccct gtagcggcgc attaagcgcg gcgggtgtgg tggttacgcg 60
cagcgtgacc gctacacttg ccagcgccct agcgcccgct cctttcgctt tcttcccttc 120
ctttctcgcc acgttcgccg gctttccccg tcaagctcta aatcgggggc tccctttagg 180
gttccgattt agtgctttac ggcacctcga ccccaaaaaa cttgattagg gtgatggttc 240
acgtagtggg ccatcgccct gatagacggt ttttcgccct ttgacgttgg agtccacgtt 300
ctttaatagt ggactcttgt tccaaactgg aacaacactc aaccctatct cggtctattc 360
ttttgattta taagggattt tgccgatttc ggcctattgg ttaaaaaatg agctgattta 420
acaaaaattt aacgcgaatt ttaacaaaat attaacgttt acaatttcag gtggcacttt 480
tcggggaaat gtgcgcggaa cccctatttg tttatttttc taaatacatt caaatatgta 540
tccgctcatg aattaattct tagaaaaact catcgagcat caaatgaaac tgcaatttat 600
tcatatcagg attatcaata ccatattttt gaaaaagccg tttctgtaat gaaggagaaa 660
actcaccgag gcagttccat aggatggcaa gatcctggta tcggtctgcg attccgactc 720
gtccaacatc aatacaacct attaatttcc cctcgtcaaa aataaggtta tcaagtgaga 780
aatcaccatg agtgacgact gaatccggtg agaatggcaa aagtttatgc atttctttcc 840
agacttgttc aacaggccag ccattacgct cgtcatcaaa atcactcgca tcaaccaaac 900
cgttattcat tcgtgattgc gcctgagcga gacgaaatac gcgatcgctg ttaaaaggac 960
aattacaaac aggaatcgaa tgcaaccggc gcaggaacac tgccagcgca tcaacaatat 1020
tttcacctga atcaggatat tcttctaata cctggaatgc tgttttcccg gggatcgcag 1080
tggtgagtaa ccatgcatca tcaggagtac ggataaaatg cttgatggtc ggaagaggca 1140
taaattccgt cagccagttt agtctgacca tctcatctgt aacatcattg gcaacgctac 1200
ctttgccatg tttcagaaac aactctggcg catcgggctt cccatacaat cgatagattg 1260
tcgcacctga ttgcccgaca ttatcgcgag cccatttata cccatataaa tcagcatcca 1320
tgttggaatt taatcgcggc ctagagcaag acgtttcccg ttgaatatgg ctcataacac 1380
cccttgtatt actgtttatg taagcagaca gttttattgt tcatgaccaa aatcccttaa 1440
cgtgagtttt cgttccactg agcgtcagac cccgtagaaa agatcaaagg atcttcttga 1500
gatccttttt ttctgcgcgt aatctgctgc ttgcaaacaa aaaaaccacc gctaccagcg 1560
gtggtttgtt tgccggatca agagctacca actctttttc cgaaggtaac tggcttcagc 1620
agagcgcaga taccaaatac tgtccttcta gtgtagccgt agttaggcca ccacttcaag 1680
aactctgtag caccgcctac atacctcgct ctgctaatcc tgttaccagt ggctgctgcc 1740
agtggcgata agtcgtgtct taccgggttg gactcaagac gatagttacc ggataaggcg 1800
cagcggtcgg gctgaacggg gggttcgtgc acacagccca gcttggagcg aacgacctac 1860
accgaactga gatacctaca gcgtgagcta tgagaaagcg ccacgcttcc cgaagggaga 1920
aaggcggaca ggtatccggt aagcggcagg gtcggaacag gagagcgcac gagggagctt 1980
ccagggggaa acgcctggta tctttatagt cctgtcgggt ttcgccacct ctgacttgag 2040
cgtcgatttt tgtgatgctc gtcagggggg cggagcctat ggaaaaacgc cagcaacgcg 2100
gcctttttac ggttcctggc cttttgctgg ccttttgctc acatgttctt tcctgcgtta 2160
tcccctgatt ctgtggataa ccgtattacc gcctttgagt gagctgatac cgctcgccgc 2220
agccgaacga ccgagcgcag cgagtcagtg agcgaggaag cggaagagcg cctgatgcgg 2280
tattttctcc ttacgcatct gtgcggtatt tcacaccgca tatatggtgc actctcagta 2340
caatctgctc tgatgccgca tagttaagcc agtatacact ccgctatcgc tacgtgactg 2400
ggtcatggct gcgccccgac acccgccaac acccgctgac gcgccctgac gggcttgtct 2460
gctcccggca tccgcttaca gacaagctgt gaccgtctcc gggagctgca tgtgtcagag 2520
gttttcaccg tcatcaccga aacgcgcgag gcagctgcgg taaagctcat cagcgtggtc 2580
gtgaagcgat tcacagatgt ctgcctgttc atccgcgtcc agctcgttga gtttctccag 2640
aagcgttaat gtctggcttc tgataaagcg ggccatgtta agggcggttt tttcctgttt 2700
ggtcactgat gcctccgtgt aagggggatt tctgttcatg ggggtaatga taccgatgaa 2760
acgagagagg atgctcacga tacgggttac tgatgatgaa catgcccggt tactggaacg 2820
ttgtgagggt aaacaactgg cggtatggat gcggcgggac cagagaaaaa tcactcaggg 2880
tcaatgccag cgcttcgtta atacagatgt aggtgttcca cagggtagcc agcagcatcc 2940
tgcgatgcag atccggaaca taatggtgca gggcgctgac ttccgcgttt ccagacttta 3000
cgaaacacgg aaaccgaaga ccattcatgt tgttgctcag gtcgcagacg ttttgcagca 3060
gcagtcgctt cacgttcgct cgcgtatcgg tgattcattc tgctaaccag taaggcaacc 3120
ccgccagcct agccgggtcc tcaacgacag gagcacgatc atgcgcaccc gtggggccgc 3180
catgccggcg ataatggcct gcttctcgcc gaaacgtttg gtggcgggac cagtgacgaa 3240
ggcttgagcg agggcgtgca agattccgaa taccgcaagc gacaggccga tcatcgtcgc 3300
gctccagcga aagcggtcct cgccgaaaat gacccagagc gctgccggca cctgtcctac 3360
gagttgcatg ataaagaaga cagtcataag tgcggcgacg atagtcatgc cccgcgccca 3420
ccggaaggag ctgactgggt tgaaggctct caagggcatc ggtcgagatc ccggtgccta 3480
atgagtgagc taacttacat taattgcgtt gcgctcactg cccgctttcc agtcgggaaa 3540
cctgtcgtgc cagctgcatt aatgaatcgg ccaacgcgcg gggagaggcg gtttgcgtat 3600
tgggcgccag ggtggttttt cttttcacca gtgagacggg caacagctga ttgcccttca 3660
ccgcctggcc ctgagagagt tgcagcaagc ggtccacgct ggtttgcccc agcaggcgaa 3720
aatcctgttt gatggtggtt aacggcggga tataacatga gctgtcttcg gtatcgtcgt 3780
atcccactac cgagatatcc gcaccaacgc gcagcccgga ctcggtaatg gcgcgcattg 3840
cgcccagcgc catctgatcg ttggcaacca gcatcgcagt gggaacgatg ccctcattca 3900
gcatttgcat ggtttgttga aaaccggaca tggcactcca gtcgccttcc cgttccgcta 3960
tcggctgaat ttgattgcga gtgagatatt tatgccagcc agccagacgc agacgcgccg 4020
agacagaact taatgggccc gctaacagcg cgatttgctg gtgacccaat gcgaccagat 4080
gctccacgcc cagtcgcgta ccgtcttcat gggagaaaat aatactgttg atgggtgtct 4140
ggtcagagac atcaagaaat aacgccggaa cattagtgca ggcagcttcc acagcaatgg 4200
catcctggtc atccagcgga tagttaatga tcagcccact gacgcgttgc gcgagaagat 4260
tgtgcaccgc cgctttacag gcttcgacgc cgcttcgttc taccatcgac accaccacgc 4320
tggcacccag ttgatcggcg cgagatttaa tcgccgcgac aatttgcgac ggcgcgtgca 4380
gggccagact ggaggtggca acgccaatca gcaacgactg tttgcccgcc agttgttgtg 4440
ccacgcggtt gggaatgtaa ttcagctccg ccatcgccgc ttccactttt tcccgcgttt 4500
tcgcagaaac gtggctggcc tggttcacca cgcgggaaac ggtctgataa gagacaccgg 4560
catactctgc gacatcgtat aacgttactg gtttcacatt caccaccctg aattgactct 4620
cttccgggcg ctatcatgcc ataccgcgaa aggttttgcg ccattcgatg gtgtccggga 4680
tctcgacgct ctcccttatg cgactcctgc attaggaagc agcccagtag taggttgagg 4740
ccgttgagca ccgccgccgc aaggaatggt gcatgcaagg agatggcgcc caacagtccc 4800
ccggccacgg ggcctgccac catacccacg ccgaaacaag cgctcatgag cccgaagtgg 4860
cgagcccgat cttccccatc ggtgatgtcg gcgatatagg cgccagcaac cgcacctgtg 4920
gcgccggtga tgccggccac gatgcgtccg gcgtagagga tcgagatctc gatcccgcga 4980
aattaatacg actcactata ggggaattgt gagcggataa caattcccct ctagaaataa 5040
ttttgtttaa ctttaagaag gagatatacc atgggtatga tgttctggcg cattttccgt 5100
cttgagctgc gtgtagcgtt tcgccatagc gccgaaatcg ccaacccgct gtggttcttc 5160
ctgattgtaa ttaccctttt tccgctcagt atcggtccgg agccgcaact gctggcgcgt 5220
attgcaccgg gcattatctg ggttgctgcg ctgctttcat ccttgctggc gctggaacga 5280
ctgttccgtg acgatttgca ggacggcagt cttgaacaat tgatgttgtt gccgttaccc 5340
ttgcccgccg ttgtgctggc gaaggtgatg gcgcactgga tggtaaccgg tctgccgtta 5400
ctcatccttt cgccactggt agcaatgcta ctgggaatgg atgtttatgg ctggcaagtg 5460
atggcgctga cgctgctgct gggaacgcct acgcttggct ttctcggtgc accgggcgtg 5520
gcgctgacag tgggacttaa gcgcggtggt gtgctgctca gcatactggt gttaccgctg 5580
actatcccat tactcatctt tgccaccgcc gcgatggacg cggcttctat gcatttgccc 5640
gttgacgggt atctggcaat tttaggcgcg ttgctggcag gcaccgcgac attaagtcct 5700
tttgcgacgg cggcagcgtt acgaatcagc attcaaggat ccggactgca ggagaacctg 5760
tacttccaat cccaccatat gtctaaaggt gaagaactgt tcaccggtgt tgttccgatc 5820
ctggttgaac tggacggtga cgttaacggt cacaaattct ctgttcgtgg tgaaggtgaa 5880
ggtgacgcta ccaacggtaa actgaccctg aaattcatct gcaccaccgg taaactgccg 5940
gttccgtggc cgaccctggt taccaccctg acctacggtg ttcagtgctt ctctcgttac 6000
ccggaccaca tgaaacgtca cgacttcttc aaatctgcta tgccggaagg ttacgttcag 6060
gaacgtacca tctctttcaa agacgacggt acctacaaaa cccgtgctga agttaaattc 6120
gaaggtgaca ccctggttaa ccgtatcgaa ctgaaaggta tcgacttcaa agaagacggt 6180
aacatcctgg gtcacaaact ggaatacaac ttcaactctc acaacgttta catcaccgct 6240
gacaaacaga aaaacggtat caaagctaac ttcaaaatcc gtcacaacgt tgaagacggt 6300
tctgttcagc tggctgacca ctaccagcag aacaccccga tcggtgacgg tccggttctg 6360
ctgccggaca accactacct gtctacccag tctgttctgt ctaaagaccc gaacgaaaaa 6420
cgtgaccaca tggttctgct ggaattcgtt accgctgctg gtatcaccca cggtatggac 6480
gaactgtaca aactcgagca ccaccaccac caccactgag atccggctgc taacaaagcc 6540
cgaaaggaag ctgagttggc tgctgccacc gctgagcaat aactagcata accccttggg 6600
gcctctaaac gggtcttgag gggttttttg ctgaaaggag gaactatatc cggat 6655
Claims (4)
1. An expression vector of a membrane protein CcmB is an expression plasmid pLy077-CcmB, and is characterized in that the nucleotide sequence is shown as SEQ ID NO.2 and comprises: the bacteriophage T7 promoter; an escherichia coli ribosome binding site which comprises an NcoI sequence CCATGG, an escherichia coli membrane protein CcmB sequence shown in SEQ ID NO.1 and a BamHI site GGATCC; a tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; NdeI restriction site CATATG; a hyper-folding Venus fluorescent protein coding sequence; XhoI cleavage site CTCGAG; 6 histidine sites and the stop codon TAG.
2. The method for expressing and purifying the expression vector of the membrane protein CcmB according to claim 1, which comprises the following steps:
step 1, preparing an escherichia coli membrane protein CcmB expression vector mutant strain: transforming an expression vector of the membrane protein CcmB, namely expression plasmid pLy077-CcmB into host escherichia coli, coating the host escherichia coli on an agar plate containing antibiotics and 0.1mM IPTG, and selecting yellow-green positive monoclonal bacteria for amplification culture and induced expression;
and 2, inoculating the selected mutant strain transformant into a culture medium for amplification culture, and carrying out large-scale induction expression on the membrane protein Ccmc by using 1mM IPTG.
3. The method for expression purification according to claim 1, wherein in step 1, the Escherichia coli is Escherichia coli BL21(DE3) or Escherichia coli C43(DE 3).
4. The expression purification method according to claim 1, wherein in step 2, the culture medium is LB medium or TB medium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010048422.1A CN113136394A (en) | 2020-01-16 | 2020-01-16 | Expression vector of membrane protein CcmB and expression purification method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010048422.1A CN113136394A (en) | 2020-01-16 | 2020-01-16 | Expression vector of membrane protein CcmB and expression purification method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113136394A true CN113136394A (en) | 2021-07-20 |
Family
ID=76808205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010048422.1A Pending CN113136394A (en) | 2020-01-16 | 2020-01-16 | Expression vector of membrane protein CcmB and expression purification method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113136394A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103667332A (en) * | 2013-12-11 | 2014-03-26 | 武汉华美生物工程有限公司 | Expression vector containing green fluorescent protein gene and construction method and application thereof |
CN110382700A (en) * | 2017-12-12 | 2019-10-25 | 韩国科学技术院 | Use the extracellular ferroheme generation method of metabolic engineering microorganism |
-
2020
- 2020-01-16 CN CN202010048422.1A patent/CN113136394A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103667332A (en) * | 2013-12-11 | 2014-03-26 | 武汉华美生物工程有限公司 | Expression vector containing green fluorescent protein gene and construction method and application thereof |
CN110382700A (en) * | 2017-12-12 | 2019-10-25 | 韩国科学技术院 | Use the extracellular ferroheme generation method of metabolic engineering microorganism |
Non-Patent Citations (4)
Title |
---|
CHRISTENSEN OLAF: "CcmA and CcmB, an ABC transporter involved in cytochrome c maturation", 《UNIVERSITY OF BERNE DOCTORAL THESIS》 * |
ROBERT E. FEISSNER ET AL.: "ABC transporter-mediated release of a haem chaperone allows cytochrome c biogenesis", 《MOLECULAR MICROBIOLOGY》 * |
ZHANG ET AL.: "High‑level production of membrane proteins in E. coli BL21(DE3) by omitting the inducer IPTG", 《MICROB CELL FACT》 * |
无: "heme exporter protein ccmB", 《NCBI:WP_000971730.1》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111304232B (en) | Method for purifying protein based on membrane surface fusion expression strategy and application thereof | |
CN111454978B (en) | Surface display engineering bacterium for specifically adsorbing heavy metal lead and construction method and application thereof | |
CN111850007B (en) | Cellulosobody docking protein combination mutant 36864 applicable to low calcium ion concentration and application | |
CN111848758B (en) | Cellulosome docking protein mutant suitable for low calcium ion concentration and application | |
CN113621638A (en) | Method for constructing Escherichia coli producing L-serine | |
CN113151214B (en) | Protein PnlipA with lipase activity and gene and application thereof | |
CN114875004B (en) | High-stereoselectivity R-transketolase mutant and encoding gene and application thereof | |
CN112592877B (en) | Recombinant escherichia coli for over-expressing lsrC gene and construction method and application thereof | |
CN111848757B (en) | Cellulosome docking protein combined mutant 36862 suitable for low calcium ion concentration and application | |
CN115216485A (en) | Amikacin-resistant recombinant plasmid pET28a (+) -rmtB and application thereof | |
CN112501103B (en) | Recombinant escherichia coli for over-expressing lsrB gene and construction method and application thereof | |
CN111850005B (en) | Cellulosome docking protein combined mutant 36863 suitable for low calcium ion concentration and application | |
CN113122561B (en) | Expression vector of membrane protein SohB and expression and purification method thereof | |
CN113122558B (en) | Expression vector of membrane protein AmpG and expression and purification method thereof | |
CN114150002A (en) | Light-operated gene switch and application thereof | |
CN113583928A (en) | Salmonella typhimurium green fluorescent strain and construction method thereof | |
KR20210125992A (en) | Bacterial expression vectors for enhanced protein secretion | |
CN113136394A (en) | Expression vector of membrane protein CcmB and expression purification method thereof | |
CN113122560A (en) | Expression vector of membrane protein FieF and expression and purification method thereof | |
CN113136395A (en) | Expression vector of membrane protein YcbM and expression and purification method thereof | |
CN113122559A (en) | Expression vector of membrane protein SecF and expression and purification method thereof | |
CN113122562A (en) | Expression vector of membrane protein YddG and expression and purification method thereof | |
CN113122557A (en) | Expression vector of membrane protein AmtB and expression purification method thereof | |
CN114591985B (en) | Mutant pectin lyase and application thereof | |
CN114774452B (en) | Construction method and application of engineering escherichia coli for adsorbing mercury ions in solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210720 |
|
RJ01 | Rejection of invention patent application after publication |